SCHEMBL6502800

SCHEMBL6502800

O=C1C(Cl)=C(NC2CCN(Cc3ccccc3)CC2)C(=O)c2ccccc21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 3/20 0.76
▸ ACHE P22303 3/20 0.76
▸ MALT1 Q9UDY8 2/20 0.65
▸ KDM4E B2RXH2 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ BACE1 P56817 2/20 0.51
▸ HTT P42858 2/20 0.51
▸ KMT2A Q03164 2/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ SIGMAR1 Q99720 2/20 0.50
▸ DRD2 P14416 1/20 0.50
▸ DRD4 P21917 1/20 0.50
▸ DRD3 P35462 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ NSD2 O96028 1/20 0.49
▸ HSP90AA1 P07900 1/20 0.49
▸ G6PD P11413 1/20 0.49
▸ CCR6 P51684 1/20 0.49
▸ HKDC1 Q2TB90 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24328047 0.83 ACHE (0.57) BCHEACHEMALT1KDM4EGAA
SCHEMBL11798271 0.79 MAPT (0.56) BCHEACHEKDM4EGAAHTT
SCHEMBL17249971 0.78 MAPT (0.54) BCHEACHEKDM4EGAAHTT
SCHEMBL11798305 0.78 MAPT (0.54) BCHEACHEKDM4EGAAHTT
SCHEMBL918426 0.74 KDM4E (0.66) BCHEACHEMALT1KDM4EGAA
SCHEMBL7840653 0.73 GAA (0.68) BCHEACHEMALT1KDM4EGAA
SCHEMBL924357 0.72 ACHE (0.68) BCHEACHEKDM4EGAABACE1
SCHEMBL10768489 0.71 NSD2 (0.64) GAAHTTKMT2AMAPK1SIGMAR1
SCHEMBL2840739 0.71 ACHE (0.70) BCHEACHEKDM4EGAABACE1
SCHEMBL6335815 0.71 HTT (0.67) BCHEACHEKDM4EGAABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032794-A1 Diamine derivatives of quinone and uses thereof CLINICAL DATA, INC. 2005-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032794-A1 Diamine derivatives of quinone and uses thereof NQO1, DPYD, NQO2 BCHE 4148/4885ACHE 3776/4885MALT1 3684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback